Lantheus Holdings, Inc. (LNTH)
NASDAQ: LNTH · IEX Real-Time Price · USD
78.18
+10.79 (16.01%)
At close: May 2, 2024, 4:00 PM
77.70
-0.48 (-0.61%)
After-hours: May 2, 2024, 7:16 PM EDT

Lantheus Holdings Revenue

Lantheus Holdings had revenue of $1.37B in the twelve months ending March 31, 2024, with 32.98% growth year-over-year. Revenue in the quarter ending March 31, 2024 was $369.98M with 23.00% year-over-year growth. In the year 2023, Lantheus Holdings had annual revenue of $1.30B with 38.65% growth.

Revenue (ttm)
$1.37B
Revenue Growth
+32.98%
P/S Ratio
4.13
Revenue / Employee
$1,554,471
Employees
834
Market Cap
5.36B USD

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 20231.30B361.37M38.65%
Dec 31, 2022935.06M509.85M119.91%
Dec 31, 2021425.21M85.80M25.28%
Dec 31, 2020339.41M-7.93M-2.28%
Dec 31, 2019347.34M3.96M1.15%
Dec 31, 2018343.37M12.00M3.62%
Dec 31, 2017331.38M29.53M9.78%
Dec 31, 2016301.85M8.39M2.86%
Dec 31, 2015293.46M-8.14M-2.70%
Dec 31, 2014301.60M17.93M6.32%
Dec 31, 2013283.67M-4.43M-1.54%
Dec 31, 2012288.11M--
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Organon & Co. 6.26B
Perrigo Company 4.66B
Bausch + Lomb 4.31B
Haemonetics 1.27B
Halozyme Therapeutics 829.25M
Doximity 468.33M
CRISPR Therapeutics AG 371.21M
Glaukos 314.71M
Revenue Rankings